MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: A loss for breast cancer multidrug-resistant research

Medical Oncology

Volumn 28, Issue SUPPL. 1, 2011, Pages

  Ke, Weifeng ^a   Yu, Pei ^a   Wang, Jianfeng ^a   Wang, Ruitao ^a   Guo, Chongyong ^a   Zhou, Ling ^a   Li, Changchun ^a   Li, Ke ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Breast cancer; DNA fingerprinting; MCF 7 ADR; Misidentification; NCI ADR RES

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P;

ARTICLE; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; CELL STRAIN MCF 7 ADR; CELL VACUOLE; CELLULAR DISTRIBUTION; DNA FINGERPRINTING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOPODIUM;

EID: 84655164947     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9747-1     Document Type: Article

References (24)

1. G Batist A Tulpule BK Sinha AG Katki CE Myers 1986 Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells J Biol Chem 261 15544 15549 (Pubitemid 17208781)
2. U Scherf DT Ross M Waltham LH Smith JK Lee 2000 A gene expression database for the molecular pharmacology of cancer Nat Genet 24 236 244 (Pubitemid 30132190)
3. YJ Moon ME Morris 2007 Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats Mol Pharm 4 865 872
4. W Jin Y Liu SG Xu WJ Yin JJ Li 2010 UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs Breast Cancer Res Treat 124 39 48
5. DA Scudiero A Monks EA Sausville 1998 Cell line designation change: multidrug-resistant cell line in the NCI anticancer screen J Natl Cancer Inst 90 862 (Pubitemid 28280554)
6. F Pirnia M Breuleux E Schneider M Hochmeister SE Bates 2000 Uncertain identity of doxorubicin-resistant MCF-7 cell lines expressing mutated p53 J Natl Cancer Inst 92 1535 1536
7. DT Ross U Scherf MB Eisen CM Perou C Rees 2000 Systematic variation in gene expression patterns in human cancer cell lines Nat Genet 24 227 235 (Pubitemid 30132189)
8. K Mehta E Devarajan J Chen A Multani S Pathak 2002 Multidrug-resistant MCF-7 cells: an identity crisis? J Natl Cancer Inst 94 1652 1654
9. Y Hathout ML Gehrmann A Chertov C Fenselau 2004 Proteomic phenotyping: metastatic and invasive breast cancer Cancer Lett 210 245 253 (Pubitemid 38748695)
10. LA Garraway HR Widlund MA Rubin G Getz AJ Berger 2005 Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma Nature 436 117 122 (Pubitemid 40966196)
11. M Liscovitch D Ravid 2007 A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells Cancer Lett 245 350 352 (Pubitemid 44959366)
12. PL Lorenzi WC Reinhold S Varma AA Hutchinson Y Pommier 2009 DNA fingerprinting of the NCI-60 cell line panel Mol Cancer Ther 8 713 724
13. E Devarajan J Chen AS Multani S Pathak AA Sahin 2002 Human breast cancer MCF-7 cell line contains inherently drug-resistant subclones with distinct genotypic and phenotypic features Int J Oncol 20 913 920
14. JR Masters JA Thomson B Daly-Burns YA Reid WG Dirks 2001 Short tandem repeat profiling provides an international reference standard for human cell lines Proc Natl Acad Sci USA 98 8012 8017 (Pubitemid 32642678)
15. B Ogretmen AR Safa 1997 Expression of the mutated p53 tumor suppressor protein and its molecular and biochemical characterization in multidrug resistant MCF-7/Adr human breast cancer cells Oncogene 14 499 506 (Pubitemid 27087113)
16. NY Lukyanova NV Rusetskya NA Tregubova VF Chekhun 2009 Molecular profile and cell cycle in MCF-7 cells resistant to cisplatin and doxorubicin Exp Oncol 31 87 91
17. ST Chen TL Pan YC Tsai CM Huang 2002 Proteomics reveals protein profile changes in doxorubicin-treated MCF-7 human breast cancer cells Cancer Lett 181 95 107
18. AV Roschke G Tonon KS Gehlhaus N [tmp] McTyre KJ Bussey 2003 Karyotypic complexity of the NCI-60 drug-screening panel Cancer Res 63 8634 8647 (Pubitemid 38064038)
19. DA Gewirtz 1999 A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin Biochem Pharmacol 57 727 741 (Pubitemid 29094544)
20. S Reymann J Borlak 2008 Topoisomerase II inhibition involves characteristic chromosomal expression patterns BMC Genomics 9 324
21. EW Thompson M Waltham SJ Ramus AM Hutchins JE Armes 2004 LCC15-mb cells are MDA-MB-435: a review of misidentified breast and prostate cell lines Clin Exp Metastasis 21 535 541
22. M Lacroix 2008 Persistent use of "false" cell lines Int J Cancer 122 1 4 (Pubitemid 350209971)
23. RM Nardone 2007 Eradication of cross-contaminated cell lines: a call for action Cell Biol Toxicol 23 367 372
24. UKCCCR. Ukcccr guidelines for the use of cell lines in cancer research. Br J Cancer. 2000;82:1495-1509.